Table 9 Reasons for participants discontinuing DTG-based ART (n = 53)
Reason | Frequency | Proportion (%) |
|---|---|---|
Participant transferred out to another health facilities | 34 | 64.2 |
Participant lost to follow-up | 10 | 18.9 |
Participant experiencing side effects | 8 | 15.1 |
 Type of SE:   Neuropsychiatric (n = 6)    Insomnia (n = 3); Depression (n = 1); Confusion (n = 2)   Central Nervous System (8)    Dizziness (n = 5); Headaches (n = 2); Neuralgia (n = 1)    Gastrointestinal (7)    Nausea (n = 1); Vomiting (n = 1); Abdominal pain (n = 4); Diarrhoea (n = 1)    Dermatological (n = 2)     Rash (n = 2)   Musculoskeletal (n = 4)    Malaise (n = 4)   Miscellaneous (n = 4)    Enlargement of breasts (n = 2); Facial swelling (n = 1); Weight gain (n = 1) |  |  |
Other (participant wanted to conceive) | 1 | 1.8 |